Showing 13 to 24 of 217 results
FDA Urges Child-Resistant Packaging for Nicotine Pouches Amid Rise in Child Exposures
The FDA is urging nicotine pouch manufacturers to use child-resistant packaging following a rise in accidental nicotine pouch exposures among young children, many resulting in nicotine poisoning.
FDA Urges Child-Resistant Packaging for Nicotine Pouches Amid Rise in Child Exposures
The FDA is urging nicotine pouch manufacturers to use child-resistant packaging following a rise in accidental nicotine pouch exposures among young children, many resulting in nicotine poisoning.
Progress
36% Bias Score
E-cigarette Sales Surge Despite Health Concerns
Between 2019 and 2023, e-cigarette sales increased by 49%, yet over 1.6 million youths vape, mostly flavored varieties, despite vaping's unproven safety and potential health risks, including nicotine addiction and exposure to toxic chemicals.
E-cigarette Sales Surge Despite Health Concerns
Between 2019 and 2023, e-cigarette sales increased by 49%, yet over 1.6 million youths vape, mostly flavored varieties, despite vaping's unproven safety and potential health risks, including nicotine addiction and exposure to toxic chemicals.
Progress
40% Bias Score
COVID-19 Vaccine Availability Changes at CVS and Walgreens
CVS and Walgreens are altering their COVID-19 vaccination policies in several states due to varying state regulations and CDC guidelines, impacting access for certain age groups and health conditions.
COVID-19 Vaccine Availability Changes at CVS and Walgreens
CVS and Walgreens are altering their COVID-19 vaccination policies in several states due to varying state regulations and CDC guidelines, impacting access for certain age groups and health conditions.
Progress
32% Bias Score
FDA Suspends Chikungunya Vaccine License Due to Serious Side Effects
The U.S. FDA suspended the license for the Ixchiq chikungunya vaccine due to four reports of adverse events, three of which were serious and occurred in individuals aged 70-82. This follows the EMA's initiation of a review and comes amid a WHO warning of a potential large chikungunya outbreak.
FDA Suspends Chikungunya Vaccine License Due to Serious Side Effects
The U.S. FDA suspended the license for the Ixchiq chikungunya vaccine due to four reports of adverse events, three of which were serious and occurred in individuals aged 70-82. This follows the EMA's initiation of a review and comes amid a WHO warning of a potential large chikungunya outbreak.
Progress
40% Bias Score
Narrowed Covid-19 Vaccine Recommendations May Leave Many Facing Unexpected Costs
The FDA and CDC will likely recommend Covid-19 vaccines this fall only for adults 65+ and those with underlying health conditions, potentially leaving others with substantial out-of-pocket costs due to changes in insurance coverage; healthy adults and children can still get the vaccine but may have ...
Narrowed Covid-19 Vaccine Recommendations May Leave Many Facing Unexpected Costs
The FDA and CDC will likely recommend Covid-19 vaccines this fall only for adults 65+ and those with underlying health conditions, potentially leaving others with substantial out-of-pocket costs due to changes in insurance coverage; healthy adults and children can still get the vaccine but may have ...
Progress
44% Bias Score
FDA Seeks Emergency Ban of Kratom Alkaloid 7-OH
The FDA urgently requested the DEA to classify 7-hydroxymitragynine (7-OH), a kratom alkaloid, as a Schedule I controlled substance due to concerns over potential abuse, despite limited data and the compound's potential medicinal benefits; the DEA will decide whether to immediately ban it or undergo...
FDA Seeks Emergency Ban of Kratom Alkaloid 7-OH
The FDA urgently requested the DEA to classify 7-hydroxymitragynine (7-OH), a kratom alkaloid, as a Schedule I controlled substance due to concerns over potential abuse, despite limited data and the compound's potential medicinal benefits; the DEA will decide whether to immediately ban it or undergo...
Progress
56% Bias Score
Stratus" Covid-19 Variant Prompts US Vaccine Restrictions
In 2025, the US FDA approved updated Covid-19 vaccines for adults 65+ and those with high-risk conditions, prompting concerns about access and potential outbreaks due to the spread of the "Stratus" variant.
Stratus" Covid-19 Variant Prompts US Vaccine Restrictions
In 2025, the US FDA approved updated Covid-19 vaccines for adults 65+ and those with high-risk conditions, prompting concerns about access and potential outbreaks due to the spread of the "Stratus" variant.
Progress
40% Bias Score
Colorado Prioritizes Independent Vaccine Guidance Amidst Federal Changes
Following the FDA's approval of new COVID-19 vaccines with eligibility restrictions and Robert F. Kennedy Jr.'s changes to the CDC's vaccine advisory panel, Colorado passed a law allowing its health board to consult sources beyond the CDC for vaccine recommendations.
Colorado Prioritizes Independent Vaccine Guidance Amidst Federal Changes
Following the FDA's approval of new COVID-19 vaccines with eligibility restrictions and Robert F. Kennedy Jr.'s changes to the CDC's vaccine advisory panel, Colorado passed a law allowing its health board to consult sources beyond the CDC for vaccine recommendations.
Progress
48% Bias Score
FDA Suspends Chikungunya Vaccine Ixchiq Due to Severe Side Effects
The U.S. FDA suspended the chikungunya vaccine Ixchiq due to new reports of severe side effects in four patients aged 55-82, halting U.S. sales and distribution; this follows previous suspensions in France and the EU, raising concerns about its future.
FDA Suspends Chikungunya Vaccine Ixchiq Due to Severe Side Effects
The U.S. FDA suspended the chikungunya vaccine Ixchiq due to new reports of severe side effects in four patients aged 55-82, halting U.S. sales and distribution; this follows previous suspensions in France and the EU, raising concerns about its future.
Progress
44% Bias Score
Lawsuit Challenges FDA Mifepristone Restrictions
In Honolulu, a lawsuit challenges FDA restrictions on the abortion drug mifepristone, arguing that they're unscientific and hinder access for those in low-income or rural areas; the judge will decide if these restrictions violate the law.
Lawsuit Challenges FDA Mifepristone Restrictions
In Honolulu, a lawsuit challenges FDA restrictions on the abortion drug mifepristone, arguing that they're unscientific and hinder access for those in low-income or rural areas; the judge will decide if these restrictions violate the law.
Progress
40% Bias Score
Walmart Recalls Frozen Shrimp Due to Radioactive Contamination
Walmart recalled three lots of its Great Value brand frozen shrimp from 13 states after the FDA found Cesium-137, a radioactive isotope, in imported products from Indonesia; while the risk is considered low, the FDA advises discarding affected products to avoid potential health problems from prolong...
Walmart Recalls Frozen Shrimp Due to Radioactive Contamination
Walmart recalled three lots of its Great Value brand frozen shrimp from 13 states after the FDA found Cesium-137, a radioactive isotope, in imported products from Indonesia; while the risk is considered low, the FDA advises discarding affected products to avoid potential health problems from prolong...
Progress
40% Bias Score
Florida Bans Potent Kratom Extract 7-OH Amid Opioid Crisis Fears
The FDA and Florida are taking action against 7-OH, a concentrated kratom extract estimated to be 10 to 13 times stronger than morphine, due to its opioid-like effects and potential to cause a new opioid crisis; at least one death has been attributed to 7-OH.
Florida Bans Potent Kratom Extract 7-OH Amid Opioid Crisis Fears
The FDA and Florida are taking action against 7-OH, a concentrated kratom extract estimated to be 10 to 13 times stronger than morphine, due to its opioid-like effects and potential to cause a new opioid crisis; at least one death has been attributed to 7-OH.
Progress
68% Bias Score
Showing 13 to 24 of 217 results